ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,523.60
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,876.39
      3.17%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Gilead Sciences Inc (GILD)

      7. Gilead Sciences Inc (GILD) Financials

      Gilead Sciences Inc

      Gilead Sciences Inc (GILD)

      DMG Mori AG
      DMG Mori AG
      DMG Mori AG
      DMG Mori AG
      Guild Esports Plc
      77.01
      0.50
      (0.65%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      76.9992
      -0.0108
      ( -0.01% )
      After Hours: 7:17PM
      Delayed by 15 minutes

      Gilead Sciences Inc Financial Summary

      The current GILD market cap is 95.93B. The company's latest EPS is USD 4.5471 and P/E is 16.94.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 6.35B6.6B7.05B7.11B6.69B
      Operating Income 1.7B1.67B2.63B1.61B-4.32B
      Net Income 1.01B1.05B2.18B1.43B-4.17B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 22.45B24.69B27.31B27.28B27.12B
      Operating Income 4.29B4.07B9.92B7.33B7.61B
      Net Income 5.39B123M6.23B4.59B5.67B

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 61.88B62.34B62.37B62.13B56.29B
      Total Liabilities 40.94B41.24B40.13B39.38B38.84B
      Total Equity 20.94B21.09B22.24B22.75B17.46B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 61.63B68.41B67.95B63.17B62.13B
      Total Liabilities 38.98B50.19B46.89B41.96B39.38B
      Total Equity 22.65B18.22B21.06B21.21B22.75B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 1.75B4.08B5.84B8.01B2.22B
      Investing -826M-1.31B-1.54B-2.27B-2.21B
      Financing -1.41B-2.51B-4.03B-5.13B-1.36B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 9.14B8.17B11.38B9.07B8.01B
      Investing -7.82B-14.62B-3.13B-2.47B-2.27B
      Financing -7.63B770M-8.88B-6.47B-5.13B

      Stats and Ratios

      Market Cap 95.93B
      Price to Earnings Ratio 16.94
      Price to Sales Ratio 3.54
      Price to Cash Ratio 15.77
      Price to Book Ratio 4.22
      Dividend Yield 3.95%

      Share Statistics

      Shares Outstanding 1.25B
      Average Volume (1 week) 6.96M
      Average Volume (1 Month) 6.17M
      52 Week Change 0.30%
      52 Week High 87.865
      52 Week Low 62.07
      Spread (Intraday) 0.63 (0.82%)

      Company Info

      Company Name Gilead Sciences Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.gilead.com
      Industry biological pds,ex diagnstics (2836)